dabrafenib
(BFSMGDJOXZAERB-UHFFFAOYSA-N)
Structure
- SMILES
- Nc1nccc(n1)c1sc(nc1c1cccc(c1F)NS(=O)(=O)c1c(F)cccc1F)C(C)(C)C
- Type(s)
- Approved; Investigational
- ATC code(s)
- L01XE23
- Molecular Formula:
- C23H20F3N5O2S2
- Molecular Weight:
- 519.562
- Log P:
- 7.0999
- Hydrogen Bond Acceptor:
- 8
- Hydrogen Bond Donor:
- 2
- TPSA:
- 147.48
- CAS Number(s):
- 1195765-45-7
Synonym(s)
1.
dabrafenib
2.
GSK 2118436
3.
GSK-2118436
4.
GSK2118436
External Link(s)
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Fatigue | FAERS: 57 Canada Vigilance: 6 | Canada Vigilance SIDER US FAERS | |
| 2 | Nausea | FAERS: 51 Canada Vigilance: 7 | Canada Vigilance SIDER US FAERS | |
| 3 | Chills | FAERS: 50 Canada Vigilance: 7 | Canada Vigilance SIDER US FAERS | |
| 4 | Malignant neoplasm progression | FAERS: 41 Canada Vigilance: 6 | Canada Vigilance US FAERS | |
| 5 | Arthralgia | FAERS: 39 Canada Vigilance: 2 | Canada Vigilance SIDER US FAERS | |
| 6 | Headache | FAERS: 39 Canada Vigilance: 5 | Canada Vigilance SIDER US FAERS | |
| 7 | Vomiting | FAERS: 38 Canada Vigilance: 8 | Canada Vigilance SIDER US FAERS | |
| 8 | Pain | FAERS: 36 Canada Vigilance: 4 | Canada Vigilance US FAERS | |
| 9 | Disease Progression | FAERS: 33 Canada Vigilance: 5 | Canada Vigilance SIDER US FAERS | |
| 10 | Product use in unapproved indication | FAERS: 29 | US FAERS | |
| 11 | Malaise | FAERS: 28 Canada Vigilance: 4 | Canada Vigilance US FAERS | |
| 12 | Drug ineffective | FAERS: 27 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 13 | Visual Impairment | FAERS: 23 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 14 | Alopecia | FAERS: 22 Canada Vigilance: 1 | Canada Vigilance SIDER US FAERS | |
| 15 | Asthenia | FAERS: 22 Canada Vigilance: 5 | Canada Vigilance SIDER US FAERS | |
| 16 | Hyperkeratosis | FAERS: 21 | SIDER US FAERS | |
| 17 | Myalgia | FAERS: 21 Canada Vigilance: 1 | Canada Vigilance SIDER US FAERS | |
| 18 | Dizziness | FAERS: 20 Canada Vigilance: 2 | Canada Vigilance SIDER US FAERS | |
| 19 | Basal cell carcinoma | FAERS: 17 | SIDER US FAERS | |
| 20 | Erythema | FAERS: 13 Canada Vigilance: 3 | Canada Vigilance SIDER US FAERS | |
| 21 | Product use issue | FAERS: 13 | US FAERS | |
| 22 | Pruritus | FAERS: 13 Canada Vigilance: 1 | Canada Vigilance SIDER US FAERS | |
| 23 | Tremor | FAERS: 12 | US FAERS | |
| 24 | Back Pain | FAERS: 11 Canada Vigilance: 2 | Canada Vigilance SIDER US FAERS | |
| 25 | Skin Papilloma | FAERS: 11 Canada Vigilance: 4 | Canada Vigilance SIDER US FAERS | |
| 26 | Dehydration | FAERS: 10 Canada Vigilance: 1 | Canada Vigilance SIDER US FAERS | |
| 27 | Dry skin | FAERS: 10 Canada Vigilance: 1 | Canada Vigilance SIDER US FAERS | |
| 28 | Squamous cell carcinoma | FAERS: 10 Canada Vigilance: 1 | Canada Vigilance SIDER US FAERS | |
| 29 | General physical health deterioration | FAERS: 9 | US FAERS | |
| 30 | Joint swelling | FAERS: 9 | US FAERS | |
| 31 | Urinary tract infection | FAERS: 9 Canada Vigilance: 1 | Canada Vigilance SIDER US FAERS | |
| 32 | Abdominal discomfort | FAERS: 8 Canada Vigilance: 1 | Canada Vigilance SIDER US FAERS | |
| 33 | Drug dose omission | FAERS: 8 | US FAERS | |
| 34 | Pneumonia | FAERS: 8 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 35 | Therapy cessation | FAERS: 8 | US FAERS | |
| 36 | Abdominal Pain | FAERS: 7 | SIDER US FAERS | |
| 37 | Aphasia | FAERS: 7 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 38 | Eye pain | FAERS: 7 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 39 | Incorrect dose administered | FAERS: 7 | US FAERS | |
| 40 | Neutropenia | FAERS: 7 | SIDER US FAERS | |
| 41 | Night sweats | FAERS: 7 | SIDER US FAERS | |
| 42 | Peripheral swelling | FAERS: 7 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 43 | Uveitis | FAERS: 7 Canada Vigilance: 5 | Canada Vigilance SIDER US FAERS | |
| 44 | Adverse event | FAERS: 6 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 45 | Feeling abnormal | FAERS: 6 | US FAERS | |
| 46 | Lower respiratory tract infection | FAERS: 6 | US FAERS | |
| 47 | Nasopharyngitis | FAERS: 6 | SIDER US FAERS | |
| 48 | Photophobia | FAERS: 6 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 49 | Sepsis | FAERS: 6 | US FAERS | |
| 50 | Skin lesion | FAERS: 6 | SIDER US FAERS | |
| 51 | Somnolence | FAERS: 6 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 52 | Squamous cell carcinoma of skin | FAERS: 6 | SIDER US FAERS | |
| 53 | Swelling | FAERS: 6 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 54 | Therapy change | FAERS: 6 | US FAERS | |
| 55 | Acne | FAERS: 5 | US FAERS | |
| 56 | Bone pain | FAERS: 5 | US FAERS | |
| 57 | Feeling Cold | FAERS: 5 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 58 | Inappropriate schedule of drug administration | FAERS: 5 | US FAERS | |
| 59 | Infection | FAERS: 5 Canada Vigilance: 1 | Canada Vigilance SIDER US FAERS | |
| 60 | Myocardial Infarction | FAERS: 5 | US FAERS | |
| 61 | Thrombocytopenia | FAERS: 5 | SIDER US FAERS | |
| 62 | Weight decreased | FAERS: 5 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 63 | Wrong technique in product usage process | FAERS: 5 | US FAERS | |
| 64 | keratoacanthoma | FAERS: 5 Canada Vigilance: 1 | Canada Vigilance SIDER US FAERS | |
| 65 | Blood glucose increased | FAERS: 4 | US FAERS | |
| 66 | Blood sodium decreased | FAERS: 4 | US FAERS | |
| 67 | Cerebrovascular accident | FAERS: 4 | US FAERS | |
| 68 | Constipation | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance SIDER US FAERS | |
| 69 | Drug administration error | FAERS: 4 | US FAERS | |
| 70 | Febrile Neutropenia | FAERS: 4 | US FAERS | |
| 71 | Hepatitis C | FAERS: 4 | US FAERS | |
| 72 | Hypersensitivity | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance SIDER US FAERS | |
| 73 | Hypokinesia | FAERS: 4 | US FAERS | |
| 74 | Hypotension | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance SIDER US FAERS | |
| 75 | Rash erythematous | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance SIDER US FAERS | |
| 76 | Respiratory Failure | FAERS: 4 | US FAERS | |
| 77 | Skin hypertrophy | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 78 | Transaminases increased | FAERS: 4 | US FAERS | |
| 79 | Accidental exposure to product | FAERS: 3 | US FAERS | |
| 80 | Atrial Fibrillation | FAERS: 3 | US FAERS | |
| 81 | Burning sensation | FAERS: 3 | US FAERS | |
| 82 | Eczema | FAERS: 3 | US FAERS | |
| 83 | Erythema Nodosum | FAERS: 3 | US FAERS | |
| 84 | Glaucoma | FAERS: 3 | US FAERS | |
| 85 | Hepatotoxicity | FAERS: 3 | US FAERS | |
| 86 | Hospice Care | FAERS: 3 | US FAERS | |
| 87 | Lymphopenia | FAERS: 3 | SIDER US FAERS | |
| 88 | Memory impairment | FAERS: 3 | US FAERS | |
| 89 | Metastasis | FAERS: 3 | US FAERS | |
| 90 | No adverse event | FAERS: 3 | US FAERS | |
| 91 | Oropharyngeal pain | FAERS: 3 | SIDER US FAERS | |
| 92 | Pancreatitis | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance SIDER US FAERS | |
| 93 | Panniculitis | FAERS: 3 | SIDER US FAERS | |
| 94 | Productive Cough | FAERS: 3 | US FAERS | |
| 95 | Skin toxicity | FAERS: 3 | SIDER US FAERS | |
| 96 | Sudden death | FAERS: 3 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 97 | Tachycardia | FAERS: 3 | US FAERS | |
| 98 | Urinary Incontinence | FAERS: 3 | US FAERS | |
| 99 | Urticaria | FAERS: 3 | US FAERS | |
| 100 | nervous system disorder | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance SIDER US FAERS | |
| 101 | Accidental underdose | FAERS: 2 | US FAERS | |
| 102 | Acute kidney injury | FAERS: 2 | US FAERS | |
| 103 | Agitation | FAERS: 2 | US FAERS | |
| 104 | Anaphylactic shock | FAERS: 2 | US FAERS | |
| 105 | Angioedema | FAERS: 2 | US FAERS | |
| 106 | Cardiac Arrest | FAERS: 2 | US FAERS | |
| 107 | Carpal Tunnel Syndrome | FAERS: 2 | US FAERS | |
| 108 | Cellulitis | FAERS: 2 | SIDER US FAERS | |
| 109 | Central nervous system lesion | FAERS: 2 | US FAERS | |
| 110 | Chest Pain | FAERS: 2 | US FAERS | |
| 111 | Chest discomfort | FAERS: 2 | US FAERS | |
| 112 | Choking | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 113 | Cholecystitis | FAERS: 2 | US FAERS | |
| 114 | Depressed Level of Consciousness | FAERS: 2 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 115 | Dermatitis acneiform | FAERS: 2 | SIDER US FAERS | |
| 116 | Diabetes Mellitus | FAERS: 2 | US FAERS | |
| 117 | Discomfort | FAERS: 2 | US FAERS | |
| 118 | Drug administered to patient of inappropriate age | FAERS: 2 | US FAERS | |
| 119 | Dysgeusia | FAERS: 2 | US FAERS | |
| 120 | Dysuria | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 121 | Ejection Fraction Decreased | FAERS: 2 | SIDER US FAERS | |
| 122 | Erythema Multiforme | FAERS: 2 | US FAERS | |
| 123 | Flushing | FAERS: 2 | US FAERS | |
| 124 | Hemiparesis | FAERS: 2 | US FAERS | |
| 125 | Hypophagia | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 126 | Impaired driving ability | FAERS: 2 | US FAERS | |
| 127 | Inflammation | FAERS: 2 | US FAERS | |
| 128 | Influenza | FAERS: 2 | US FAERS | |
| 129 | Insurance issue | FAERS: 2 | US FAERS | |
| 130 | Keratosis pilaris | FAERS: 2 | US FAERS | |
| 131 | Lethargy | FAERS: 2 | US FAERS | |
| 132 | Leukopenia | FAERS: 2 | SIDER US FAERS | |
| 133 | Lymphadenopathy | FAERS: 2 | US FAERS | |
| 134 | Melanoma recurrent | FAERS: 2 | US FAERS | |
| 135 | Musculoskeletal Pain | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 136 | Neck Pain | FAERS: 2 | US FAERS | |
| 137 | Nephrolithiasis | FAERS: 2 | US FAERS | |
| 138 | Oncologic complication | FAERS: 2 | US FAERS | |
| 139 | Overdose | FAERS: 2 | US FAERS | |
| 140 | Palliative Care | FAERS: 2 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 141 | Pericardial effusion | FAERS: 2 | US FAERS | |
| 142 | Pneumonitis | FAERS: 2 | US FAERS | |
| 143 | Poor peripheral circulation | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 144 | Product physical issue | FAERS: 2 | US FAERS | |
| 145 | Rebound effect | FAERS: 2 | US FAERS | |
| 146 | Respiratory distress | FAERS: 2 | US FAERS | |
| 147 | Rhinalgia | FAERS: 2 | US FAERS | |
| 148 | Skin Ulcer | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 149 | Skin reaction | FAERS: 2 | US FAERS | |
| 150 | Systemic Inflammatory Response Syndrome | FAERS: 2 | US FAERS | |
| 151 | Terminal state | FAERS: 2 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 152 | Therapeutic response changed | FAERS: 2 | US FAERS | |
| 153 | Thermal burn | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 154 | Thrombosis | FAERS: 2 | US FAERS | |
| 155 | Toxicity to various agents | FAERS: 2 | US FAERS | |
| 156 | Vasculitis | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 157 | Vertigo | FAERS: 2 | US FAERS | |
| 158 | Vitreous floaters | FAERS: 2 | US FAERS | |
| 159 | Wrong drug administered | FAERS: 2 | US FAERS | |
| 160 | cancer surgery | FAERS: 2 | US FAERS | |
| 161 | furuncle | FAERS: 2 | US FAERS | |
| 162 | Abasia | FAERS: 1 | US FAERS | |
| 163 | Abdominal Infection | FAERS: 1 | US FAERS | |
| 164 | Acanthosis | FAERS: 1 | US FAERS | |
| 165 | Actinic keratosis | FAERS: 1 | SIDER US FAERS | |
| 166 | Actinomycosis | FAERS: 1 | US FAERS | |
| 167 | Acute Coronary Syndrome | FAERS: 1 | US FAERS | |
| 168 | Alanine Aminotransferase Increased | FAERS: 1 | SIDER US FAERS | |
| 169 | Allergic reaction to excipient | FAERS: 1 | US FAERS | |
| 170 | Altered state of consciousness | FAERS: 1 | US FAERS | |
| 171 | Amnesia | FAERS: 1 | US FAERS | |
| 172 | Amylase increased | FAERS: 1 | US FAERS | |
| 173 | Anxiety | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 174 | Aphagia | FAERS: 1 | US FAERS | |
| 175 | Apparent death | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 176 | Appendicitis | FAERS: 1 | US FAERS | |
| 177 | Arthritis | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 178 | Arthropathy | FAERS: 1 | US FAERS | |
| 179 | Ascites | FAERS: 1 | US FAERS | |
| 180 | Aspartate Aminotransferase Increased | FAERS: 1 | SIDER US FAERS | |
| 181 | Asthenopia | FAERS: 1 | US FAERS | |
| 182 | Astrocytoma, low grade | FAERS: 1 | US FAERS | |
| 183 | Atelectasis | FAERS: 1 | US FAERS | |
| 184 | Atrial Flutter | FAERS: 1 | US FAERS | |
| 185 | Autoimmune thyroiditis | FAERS: 1 | US FAERS | |
| 186 | BRAF V600E mutation positive | FAERS: 1 | US FAERS | |
| 187 | BRAF gene mutation | FAERS: 1 | US FAERS | |
| 188 | Bed rest | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 189 | Blood alkaline phosphatase increased | FAERS: 1 | SIDER US FAERS | |
| 190 | Blood count abnormal | FAERS: 1 | US FAERS | |
| 191 | Blood creatinine increased | FAERS: 1 | SIDER US FAERS | |
| 192 | Blood electrolytes decreased | FAERS: 1 | US FAERS | |
| 193 | Blood glucose decreased | FAERS: 1 | US FAERS | |
| 194 | Blood potassium decreased | FAERS: 1 | US FAERS | |
| 195 | Blood urine present | FAERS: 1 | US FAERS | |
| 196 | Blue Toe Syndrome | FAERS: 1 | US FAERS | |
| 197 | Brain Death | FAERS: 1 | US FAERS | |
| 198 | Bronchial wall thickening | FAERS: 1 | US FAERS | |
| 199 | Bursitis | FAERS: 1 | US FAERS | |
| 200 | Carbon dioxide increased | FAERS: 1 | US FAERS | |
| 201 | Cardiac neoplasm unspecified | FAERS: 1 | US FAERS | |
| 202 | Cerebral Thrombosis | FAERS: 1 | US FAERS | |
| 203 | Chromaturia | FAERS: 1 | US FAERS | |
| 204 | Colitis | FAERS: 1 | US FAERS | |
| 205 | Colon adenoma | FAERS: 1 | US FAERS | |
| 206 | Colon cancer recurrent | FAERS: 1 | US FAERS | |
| 207 | Concomitant disease progression | FAERS: 1 | US FAERS | |
| 208 | Conjunctivitis | FAERS: 1 | US FAERS | |
| 209 | Contrast media allergy | FAERS: 1 | US FAERS | |
| 210 | Cystitis | FAERS: 1 | US FAERS | |
| 211 | Deafness | FAERS: 1 | US FAERS | |
| 212 | Deep Vein Thrombosis | FAERS: 1 | US FAERS | |
| 213 | Dementia | FAERS: 1 | US FAERS | |
| 214 | Device related infection | FAERS: 1 | US FAERS | |
| 215 | Diplopia | FAERS: 1 | US FAERS | |
| 216 | Disseminated Intravascular Coagulation | FAERS: 1 | US FAERS | |
| 217 | Drug dispensing error | FAERS: 1 | US FAERS | |
| 218 | Drug resistance | FAERS: 1 | US FAERS | |
| 219 | Dysgraphia | FAERS: 1 | US FAERS | |
| 220 | Dysphonia | FAERS: 1 | US FAERS | |
| 221 | Electrolyte imbalance | FAERS: 1 | US FAERS | |
| 222 | Embolism | FAERS: 1 | US FAERS | |
| 223 | Emergency care examination | FAERS: 1 | US FAERS | |
| 224 | Emotional distress | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 225 | Eosinophilia | FAERS: 1 | US FAERS | |
| 226 | Escherichia urinary tract infection | FAERS: 1 | US FAERS | |
| 227 | Exophthalmos | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 228 | Eye inflammation | FAERS: 1 | US FAERS | |
| 229 | Eye ulcer | FAERS: 1 | US FAERS | |
| 230 | Fibrosarcoma metastatic | FAERS: 1 | US FAERS | |
| 231 | Folliculitis | FAERS: 1 | SIDER US FAERS | |
| 232 | Foreign body sensation in eyes | FAERS: 1 | US FAERS | |
| 233 | Full blood count decreased | FAERS: 1 | US FAERS | |
| 234 | Gait inability | FAERS: 1 | US FAERS | |
| 235 | Gamma-Glutamyltransferase Increased | FAERS: 1 | SIDER US FAERS | |
| 236 | Gastric infection | FAERS: 1 | US FAERS | |
| 237 | Gastric mucosa erythema | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 238 | Gastroenteritis | FAERS: 1 | US FAERS | |
| 239 | Glioma | FAERS: 1 | US FAERS | |
| 240 | Granulomatous dermatitis | FAERS: 1 | US FAERS | |
| 241 | Guillain-Barre Syndrome | FAERS: 1 | US FAERS | |
| 242 | Hemiplegia | FAERS: 1 | US FAERS | |
| 243 | Hepatomegaly | FAERS: 1 | US FAERS | |
| 244 | Hidradenitis | FAERS: 1 | US FAERS | |
| 245 | Hyperkinesia | FAERS: 1 | US FAERS | |
| 246 | Hyperpyrexia | FAERS: 1 | US FAERS | |
| 247 | Hypersomnia | FAERS: 1 | US FAERS | |
| 248 | Hyperthyroidism | FAERS: 1 | US FAERS | |
| 249 | Inappropriate schedule of product administration | FAERS: 1 | US FAERS | |
| 250 | Incoherent | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 251 | Incorrect drug administration rate | FAERS: 1 | US FAERS | |
| 252 | Incorrect product storage | FAERS: 1 | US FAERS | |
| 253 | Incorrect route of drug administration | FAERS: 1 | US FAERS | |
| 254 | Incorrect route of product administration | FAERS: 1 | US FAERS | |
| 255 | Intestinal Obstruction | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 256 | Intestinal Perforation | FAERS: 1 | US FAERS | |
| 257 | Intra-abdominal fluid collection | FAERS: 1 | US FAERS | |
| 258 | Iridocyclitis | FAERS: 1 | US FAERS | |
| 259 | Iritis | FAERS: 1 | US FAERS | |
| 260 | Joint neoplasm | FAERS: 1 | US FAERS | |
| 261 | Joint stiffness | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 262 | Keratitis | FAERS: 1 | US FAERS | |
| 263 | Leukocytosis | FAERS: 1 | US FAERS | |
| 264 | Lipase increased | FAERS: 1 | US FAERS | |
| 265 | Lymphocyte count decreased | FAERS: 1 | US FAERS | |
| 266 | Macular degeneration | FAERS: 1 | US FAERS | |
| 267 | Malignant melanoma stage IV | FAERS: 1 | US FAERS | |
| 268 | Medication Error | FAERS: 1 | US FAERS | |
| 269 | Metastases to abdominal wall | FAERS: 1 | US FAERS | |
| 270 | Metastases to muscle | FAERS: 1 | US FAERS | |
| 271 | Metastatic Neoplasm | FAERS: 1 | US FAERS | |
| 272 | Microembolism | FAERS: 1 | US FAERS | |
| 273 | Mole excision | FAERS: 1 | US FAERS | |
| 274 | Musculoskeletal stiffness | FAERS: 1 | US FAERS | |
| 275 | Mydriasis | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 276 | Myocarditis | FAERS: 1 | US FAERS | |
| 277 | Myositis | FAERS: 1 | US FAERS | |
| 278 | Nephrotic Syndrome | FAERS: 1 | US FAERS | |
| 279 | Nervousness | FAERS: 1 | US FAERS | |
| 280 | Neuralgia | FAERS: 1 | US FAERS | |
| 281 | Neurological decompensation | FAERS: 1 | US FAERS | |
| 282 | Neutropenic colitis | FAERS: 1 | US FAERS | |
| 283 | Neutrophilic panniculitis | FAERS: 1 | US FAERS | |
| 284 | Nocturia | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 285 | Nodule | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 286 | Noninfective encephalitis | FAERS: 1 | US FAERS | |
| 287 | Ocular discomfort | FAERS: 1 | US FAERS | |
| 288 | Oral candidiasis | FAERS: 1 | US FAERS | |
| 289 | PCO2 decreased | FAERS: 1 | US FAERS | |
| 290 | Pain of skin | FAERS: 1 | US FAERS | |
| 291 | Palatal ulcer | FAERS: 1 | US FAERS | |
| 292 | Palpitations | FAERS: 1 | US FAERS | |
| 293 | Pancreatic carcinoma | FAERS: 1 | US FAERS | |
| 294 | Papule | FAERS: 1 | US FAERS | |
| 295 | Parakeratosis | FAERS: 1 | US FAERS | |
| 296 | Parapsoriasis | FAERS: 1 | US FAERS | |
| 297 | Performance status decreased | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 298 | Peritonitis | FAERS: 1 | US FAERS | |
| 299 | Pharyngitis | FAERS: 1 | US FAERS | |
| 300 | Poor quality sleep | FAERS: 1 | US FAERS | |
| 301 | Prerenal failure | FAERS: 1 | US FAERS | |
| 302 | Product administered to patient of inappropriate age | FAERS: 1 | US FAERS | |
| 303 | Product communication issue | FAERS: 1 | US FAERS | |
| 304 | Product difficult to swallow | FAERS: 1 | US FAERS | |
| 305 | Product dose omission | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 306 | Product formulation issue | FAERS: 1 | US FAERS | |
| 307 | Product packaging issue | FAERS: 1 | US FAERS | |
| 308 | Product use complaint | FAERS: 1 | US FAERS | |
| 309 | Product used for unknown indication | FAERS: 1 | US FAERS | |
| 310 | Pulmonary Embolism | FAERS: 1 | US FAERS | |
| 311 | Pulmonary Fibrosis | FAERS: 1 | US FAERS | |
| 312 | Purpura | FAERS: 1 | US FAERS | |
| 313 | Pyelonephritis | FAERS: 1 | US FAERS | |
| 314 | Renal Colic | FAERS: 1 | US FAERS | |
| 315 | Retinal Artery Occlusion | FAERS: 1 | US FAERS | |
| 316 | Retinal Detachment | FAERS: 1 | US FAERS | |
| 317 | Retinal Vascular Disorder | FAERS: 1 | US FAERS | |
| 318 | Retroperitoneal mass | FAERS: 1 | US FAERS | |
| 319 | Sarcoma excision | FAERS: 1 | US FAERS | |
| 320 | Sciatica | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 321 | Sinusitis | FAERS: 1 | US FAERS | |
| 322 | Sleep disorder due to general medical condition, insomnia type | FAERS: 1 | US FAERS | |
| 323 | Splenomegaly | FAERS: 1 | US FAERS | |
| 324 | Stevens-Johnson Syndrome | FAERS: 1 | US FAERS | |
| 325 | Stress | FAERS: 1 | US FAERS | |
| 326 | Stridor | FAERS: 1 | US FAERS | |
| 327 | Syncope | FAERS: 1 | US FAERS | |
| 328 | Temperature intolerance | FAERS: 1 | US FAERS | |
| 329 | Tension Headache | FAERS: 1 | US FAERS | |
| 330 | Therapeutic procedure | FAERS: 1 | US FAERS | |
| 331 | Therapy non-responder | FAERS: 1 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 332 | Thirst | FAERS: 1 | US FAERS | |
| 333 | Throat cancer | FAERS: 1 | US FAERS | |
| 334 | Throat irritation | FAERS: 1 | US FAERS | |
| 335 | Tooth Infection | FAERS: 1 | US FAERS | |
| 336 | Unevaluable event | FAERS: 1 | US FAERS | |
| 337 | Unresponsive to stimuli | FAERS: 1 | US FAERS | |
| 338 | Urinary Retention | FAERS: 1 | US FAERS | |
| 339 | Urine albumin/creatinine ratio increased | FAERS: 1 | US FAERS | |
| 340 | VIIth nerve paralysis | FAERS: 1 | US FAERS | |
| 341 | Viral upper respiratory tract infection | FAERS: 1 | US FAERS | |
| 342 | Vocal Cord Paralysis | FAERS: 1 | US FAERS | |
| 343 | Walking aid user | FAERS: 1 | US FAERS | |
| 344 | Wheezing | FAERS: 1 | US FAERS | |
| 345 | White blood cell count decreased | FAERS: 1 | US FAERS | |
| 346 | Wound Infection | FAERS: 1 | US FAERS | |
| 347 | treatment failure | FAERS: 1 | US FAERS | |
| 348 | Bowen's Disease | SIDER | ||
| 349 | Creatinine increased | SIDER | ||
| 350 | Cyst | SIDER | ||
| 351 | Dermatitis | Canada Vigilance: 1 | Canada Vigilance SIDER | |
| 352 | Epistaxis | SIDER | ||
| 353 | Gastrointestinal Pain | SIDER | ||
| 354 | Infestation | SIDER | ||
| 355 | Malnutrition | SIDER | ||
| 356 | Musculoskeletal discomfort | SIDER | ||
| 357 | Nephritis | SIDER | ||
| 358 | Ocular Toxicity | SIDER | ||
| 359 | Papilloma | Canada Vigilance: 1 | Canada Vigilance SIDER | |
| 360 | Prurigo | SIDER | ||
| 361 | Rash bullous | SIDER | ||
| 362 | Reaction febrile | SIDER | ||
| 363 | Refractory hypertension | SIDER | ||
| 364 | Skin neoplasm excision | Canada Vigilance: 1 | Canada Vigilance | |
| 365 | Stomatitis | SIDER | ||
| 366 | Therapeutic response unexpected | Canada Vigilance: 2 | Canada Vigilance | |
| 367 | Venous Thromboembolism | SIDER | ||
| 368 | melanoma | 23237741 | CTD |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.